Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
PepsiCo
PEP
|
+$815M |
| 2 |
UnitedHealth
UNH
|
+$744M |
| 3 |
Broadcom
AVGO
|
+$661M |
| 4 |
Procter & Gamble
PG
|
+$651M |
| 5 |
Exxon Mobil
XOM
|
+$570M |
Top Sells
| 1 |
XYZ
Block, Inc.
XYZ
|
+$746M |
| 2 |
Schlumberger
SLB
|
+$579M |
| 3 |
PayPal
PYPL
|
+$542M |
| 4 |
Uber
UBER
|
+$497M |
| 5 |
Target
TGT
|
+$423M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Financials | 10.94% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
NIO
NIO
$12.8B
| $910K | ﹤0.01% |
93,937
-2,411
| -3% | -$23.4K |
|
727
PNC Financial Services
PNC
$79.5B
| $905K | ﹤0.01% |
7,181
+2,155
| +43% | +$271K |
|
728
Hologic
HOLX
$14.6B
| $902K | ﹤0.01% |
11,146
-988
| -8% | -$80K |
|
|
PNT
729
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $899K | ﹤0.01% |
99,189
| – | – |
|
730
Schwab US Dividend Equity ETF
SCHD
$71.6B
| $897K | ﹤0.01% |
37,068
-7,266
| -16% | -$176K |
|
731
German American Bancorp
GABC
$1.53B
| $894K | ﹤0.01% |
32,909
| – | – |
|
732
Vanda Pharmaceuticals
VNDA
$265M
| $888K | ﹤0.01% |
134,792
| – | – |
|
733
iShares US Aerospace & Defense ETF
ITA
$9.26B
| $885K | ﹤0.01% |
7,589
+1,399
| +23% | +$163K |
|
|
KDNY
734
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $877K | ﹤0.01% |
22,820
-13,083
| -36% | -$503K |
|
735
First Trust NASDAQ-100 Equal Weighted Index Fund
QQEW
$1.85B
| $874K | ﹤0.01% |
8,178
+212
| +3% | +$22.7K |
|
736
Yum China
YUMC
$16.2B
| $866K | ﹤0.01% |
15,325
-1,807
| -11% | -$102K |
|
737
Weyerhaeuser
WY
$18.1B
| $864K | ﹤0.01% |
25,788
+3,661
| +17% | +$123K |
|
738
Chubb
CB
$111B
| $856K | ﹤0.01% |
4,446
+247
| +6% | +$47.6K |
|
739
Movado Group
MOV
$426M
| $847K | ﹤0.01% |
31,582
-62
| -0.2% | -$1.66K |
|
740
QCR Holdings
QCRH
$1.32B
| $835K | ﹤0.01% |
+20,349
| New | +$835K |
|
741
Wells Fargo
WFC
$257B
| $834K | ﹤0.01% |
19,550
+1,673
| +9% | +$71.4K |
|
742
Zimmer Biomet
ZBH
$20.3B
| $832K | ﹤0.01% |
5,711
| – | – |
|
743
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.3B
| $831K | ﹤0.01% |
16,428
+6,560
| +66% | +$332K |
|
744
Origin Bancorp
OBK
$1.18B
| $821K | ﹤0.01% |
+28,009
| New | +$821K |
|
745
Ironwood Pharmaceuticals
IRWD
$187M
| $815K | ﹤0.01% |
76,604
+186
| +0.2% | +$1.98K |
|
746
Mondelez International
MDLZ
$80.6B
| $814K | ﹤0.01% |
11,157
+1,903
| +21% | +$139K |
|
747
Cogent Biosciences
COGT
$1.78B
| $812K | ﹤0.01% |
68,569
| – | – |
|
748
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.4B
| $804K | ﹤0.01% |
16,017
+3,559
| +29% | +$179K |
|
749
CF Industries
CF
$14.1B
| $785K | ﹤0.01% |
11,308
-896
| -7% | -$62.2K |
|
750
iShares US Treasury Bond ETF
GOVT
$28.2B
| $783K | ﹤0.01% |
34,210
+20,297
| +146% | +$465K |
|